← Russell 3000 cross-section

CNC CENTENE CORP

Trailing twelve months to 2026-06-30 · as filed 2026-07-28, not restated
Financials

Scale

Market cap
$32.5bn
Revenue TTM
$178.7bn
Net income TTM
$-5.1bn
Free cash flow
$9.0bn
Composite score
18.5
Sector rank
#320

Valuation

P / E
EV / EBITDA
EV / sales
0.1
FCF yield
27.58%
Earnings yield vs 10-yr
-20.44pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-2.9%
EBITDA margin
-2.5%
ROE
-22.6%
ROIC
-48.9%
Revenue growth
13.0%

Insider activity, last 90 days

Net open-market
$-12.06m
Buyers
0
Sellers
2

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Additionally, as a result of development within "Incurred related to: Prior years," the Company recorded $ 38 million and $ 69 million as a reduction to premium revenue in the six months ended June 30, 2026 and 2025, respectively, for minimum medical loss ratio (MLR) and other return of premium programs. In December 2024, the Company recorded a premium deficiency reserve of $ 92 million related to the 2025 Medicare Advantage contract year, which was increased to $ 270 million in the first quarter of 2025 and to $ 389 million in the second quarter of 2025 based on the progression of earnings during the year (with higher earnings at the beginning of the year and lower at the end of the year, g …CENTENE CORP, 10-Q, period ended 2026-06-30, filed 2026-07-28

Read the full passage →